Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]

View source ↗

Summary

An NCI-sponsored Phase 1 study evaluated a combination chemotherapy regimen in patients with metastatic or unresectable solid tumors, including recurrent or sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Prostate Cancer, Stage IV Prostate Cancer | Phase 1 | Status: COMPLETED